Table 1.
Clinical and demographic characteristics of 1139 vaccinated children and adolescents.
| 3–5 Years Old Group n = 790 |
6–11 Years Old Group n = 251 |
12–17 Years Old Group n = 98 |
|
|---|---|---|---|
| Age years, mean (SD) | 4.5 (0.8) | 8.7 (1.8) | 13.6 (1.5) |
| Gender female, n (%) | 392 (49.6) | 117(46.6) | 43 (43.9) |
| Ethnicity | |||
| Hispanic, n | 713 | 233 | 94 |
| Chilean native, n | 17 | 11 | 3 |
| White, n | 22 | 4 | 0 |
| Others, n | 38 | 3 | 1 |
| With co-morbidities | |||
| Allergic rhinitis, n | 150 | 31 | 8 |
| Asthma, n | 51 | 8 | 5 |
| Atopic dermatitis, n | 46 | 6 | 1 |
| Obesity, n | 3 | 6 | 5 |
| ENT a, n | 5 | 2 | 0 |
| Mental health b, n | 15 | 11 | 3 |
| Drugs allergy, n | 5 | 1 | 1 |
| Other allergies, n | 18 | 1 | 4 |
|
Metabolic–endocrine
disorders, n |
8 | 7 | 5 |
| Chromosomopathies c, n | 4 | 1 | 0 |
| Others, n | 77 | 21 | 5 |
| Baseline SARS-CoV-2 positive status, n (%) d | 22 (2.8) | 15 (6) | 3 (3) |
a Ear, nose and throat; b anxiety disorders, ADHD, ASD, depression, feeding disorders; c Down Syndrome and Turner Syndrome; d Baseline SARS-CoV-2 positive status was defined as a positive rapid antigen test or a positive antibody test (IgM or IgG) at enrollment.